COVID-19 pneumonia in a patient with adult T-cell leukemia-lymphoma
暂无分享,去创建一个
Y. Ohe | K. Izutsu | D. Maruyama | A. Maeshima | S. Iwata | N. Yamamoto | W. Munakata | H. Matsushita | Tatsuya Suzuki | Makiko Suzuki | Osamu Kobayashi | S. Makita | Mika Shiotsuka | S. Fukuhara | H. Ida | Rika Hosoba | N. Okada | K. Nakano | Mimiko Muroya
[1] L. Staudt,et al. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19 , 2020, Science Immunology.
[2] Alokkumar Jha,et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study , 2020, The Lancet.
[3] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[4] S. Treon,et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients , 2020, Blood.
[5] A. Gasbarrini,et al. Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection , 2020, Journal of medical virology.
[6] Yuan Wei,et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.
[7] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[8] R. Redfield,et al. Covid-19 — Navigating the Uncharted , 2020, The New England journal of medicine.
[9] Ruchong Chen,et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.
[10] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[11] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[12] Y. Furuta,et al. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase , 2017, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[13] Makoto Takeda,et al. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay , 2016, Antimicrobial Agents and Chemotherapy.
[14] K. Ishitsuka,et al. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. , 2014, The Lancet. Oncology.